|
Market Closed -
Other stock markets
|
After hours 00:56:52 | |||
| 664.52 USD | -0.51% |
|
644.27 | -3.05% |
| 07-09 | Piper Sandler Adjusts Price Target on Regeneron Pharmaceuticals to $854 From $855 | MT |
| 07-08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| Market Cap | 67.96B 59.44B 54.83B 50.64B 96.09B 6,481B 97.7B 655B 257B 3,193B 255B 250B 10,976B | P/E 2026 * |
17.3x | P/E 2027 * | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 60.12B 52.59B 48.51B 44.8B 85.01B 5,734B 86.44B 580B 228B 2,825B 226B 221B 9,711B | EV / Sales 2026 * |
3.79x | EV / Sales 2027 * | 3.27x |
| Free-Float |
72.33% | Yield 2026 * |
0.58% | Yield 2027 * | 0.66% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | -0.51% | ||
| 1 week | +1.57% | ||
| Current month | +6.57% | ||
| 1 month | +10.45% | ||
| 3 months | -11.26% | ||
| 6 months | -16.58% | ||
| Current year | -13.91% |
| 1 week | 637.72 |  | 677.92 |
| 1 month | 594.9 | | 677.92 |
| Current year | 591.52 | | 821.11 |
| 1 year | 541 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 31/12/2000 | |
| Chief Executive Officer | 73 | 07/01/1988 | |
| Director of Finance/CFO | 55 | 04/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 08/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 31/05/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 31/05/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07-01 | Sell | Director | -200 | 0.0002% | ||
| 04-30 | Sell | Director | -100 | 0.0001% | ||
| 03-31 | Sell | Director | 100 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.51% | +1.57% | +18.72% | -5.52% | 67.96B | |
| -5.16% | -8.63% | +37.37% | +202.27% | 54.4B | |
| -2.10% | +0.89% | -49.30% | -53.47% | 41.74B | |
| +5.28% | +39.50% | +39.50% | +39.50% | 40.63B | |
| -10.83% | -14.41% | +99.15% | -44.54% | 30.38B | |
| +0.12% | -7.85% | +47.16% | -29.27% | 29.37B | |
| -1.53% | -0.13% | +65.92% | +88.58% | 23.68B | |
| +3.88% | +2.16% | +11.78% | +201.51% | 19.15B | |
| -4.75% | +11.27% | +85.63% | +394.76% | 17.68B | |
| -1.59% | -1.63% | +61.04% | +130.75% | 17.14B | |
| Average | -1.72% | +1.14% | +41.70% | +92.46% | 34.21B | |
| Weighted average by Cap. | -1.72% | +0.36% | +33.89% | +67.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.87B 13.88B 12.81B 11.83B 22.44B 1,514B 22.82B 153B 60.09B 746B 59.6B 58.3B 2,564B | 17.55B 15.35B 14.16B 13.08B 24.81B 1,674B 25.23B 169B 66.43B 824B 65.89B 64.46B 2,834B |
| Net income | 4.06B 3.55B 3.27B 3.02B 5.73B 387B 5.83B 39.09B 15.35B 191B 15.23B 14.9B 655B | 5.11B 4.47B 4.12B 3.8B 7.22B 487B 7.34B 49.21B 19.33B 240B 19.17B 18.75B 825B |
| Net Debt | -7.83B -6.85B -6.32B -5.84B -11.08B -747B -11.26B -75.52B -29.66B -368B -29.41B -28.77B -1,265B | -10.5B -9.19B -8.47B -7.83B -14.85B -1,002B -15.1B -101B -39.75B -493B -39.43B -38.57B -1,696B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | US$664.52 | -0.51% | 565,814 |
| 09/07/26 | US$667.95 | +0.76% | 672,528 |
| 08/07/26 | US$662.88 | -1.97% | 746,834 |
| 07/07/26 | US$676.23 | +4.07% | 918,937 |
| 06/07/26 | US$649.81 | -0.68% | 714,338 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
